Cardiauvergne : service de télésurveillance et de coordination des soins des insuffisants cardiaques

R. Eschalier1,2, M.-C. D’Agrosa-Boiteux3, P.-H. Mannenq4, S. Vallot4, J.-P. Bastard3, J. Cassagnes3
1ISIT-CaVITI, Clermont university, BP 10448, 63001 Clermont-Ferrand, France
2Cardiology department, CHU de Clermont-Ferrand, 63003 Clermont-Ferrand, France
3GCS Cardiauvergne, BP 69, 30, place Henri-Dunant, 63003 Clermont-Ferrand, France
4Almerys, rue du Ressort, 63000 Clermont-Ferrand, France

Tài liệu tham khảo

Delahaye, 1998, Epidemiology and economic impact of heart failure in France, Arch Mal Coeur Vaiss, 91, 1307 Delahaye, 2001, Epidemiology and prognosis of cardiac insufficiency, Arch Mal Coeur Vaiss, 94, 1393 Zannad, 1999, Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study, J Am Coll Cardiol, 33, 734, 10.1016/S0735-1097(98)00634-2 1999, The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial, Lancet, 353, 9, 10.1016/S0140-6736(98)11181-9 Flather, 2005, Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS), Eur Heart J, 26, 215, 10.1093/eurheartj/ehi115 Ho, 1993, The epidemiology of heart failure: the Framingham study, J Am Coll Cardiol, 22, 6A, 10.1016/0735-1097(93)90455-A McMurray, 2012, Eur Heart J, 33, 1787, 10.1093/eurheartj/ehs104 Stewart, 2001, More “malignant” than cancer? Five-year survival following a first admission for heart failure, Eur J Heart Fail, 3, 315, 10.1016/S1388-9842(00)00141-0 1991, Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators, N Engl J Med, 325, 293, 10.1056/NEJM199108013250501 Pitt, 1999, The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators, N Engl J Med, 341, 709, 10.1056/NEJM199909023411001 Pitt, 2003, Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction, N Engl J Med, 348, 1309, 10.1056/NEJMoa030207 Zannad, 2011, Eplerenone in patients with systolic heart failure and mild symptoms, N Engl J Med, 364, 11, 10.1056/NEJMoa1009492 Labrunée, 2012, Therapeutic education in cardiovascular diseases: state of the art and perspectives, Ann Phys Rehabil Med, 55, 322, 10.1016/j.rehab.2012.04.003 Takeda, 2012, Clinical service organisation for heart failure, Cochrane Database Syst Rev, 9, 10.1002/14651858.CD002752.pub3 Agrinier, 2013, Effectiveness of a multidimensional home nurse led heart failure disease management program-a French nationwide time-series comparison, Int J Cardiol, 168, 3652, 10.1016/j.ijcard.2013.05.090 Pandor, 2013, Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation, Health Technol Assess, 17, 1, 10.3310/hta17320 Davies, 2010, Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis, Eur J Heart Fail, 12, 706, 10.1093/eurjhf/hfq056